Compare VanEck Gold Miners ETF (GDX) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Gold Miners ETF vs GeneDx Holdings Corp — how do they compare? VanEck Gold Miners ETF trades at $89.28 (market cap $25.65B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: VanEck Gold Miners ETF is far larger — about 12.7× GeneDx Holdings Corp's market cap, and VanEck Gold Miners ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Gold Miners ETF for 76 Days and GeneDx Holdings Corp for 19 Days on average.
| GDX | WGS | |
|---|---|---|
Market Cap | $25.65B | $2.02B |
Volume | 16,534,046 | 734,640 |
52-Week High | $115.84 | $167.51 |
52-Week Low | $68.28 | $34.51 |
Typical Hold Time | 76 Days | 19 Days |
Sector | — | Health |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GDX trades at $86.74, up 1.5% on the day, but technical indicators show a bearish trend with moving averages signaling sell pressure. The ETF faces headwinds from rising interest rates impacting gold miners, though some analysts see value in the sector's current valuation. Recent institutional activity shows mixed sentiment with both significant sales and purchases reported.
The outlook remains cautious given the bearish technical setup and macroeconomic pressures on gold. However, the sector's attractive valuation metrics and potential for catch-up trading if gold prices stabilize present opportunities for patient investors. Key risks include continued rate hikes and commodity price volatility.
GeneDx (WGS) trades at $67.73, down 1.17% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations, and returned to adjusted profitability early. However, 2026 fundamentals show concerning trends with a net loss of $106 million and negative profit margins. Recent news highlights product innovations and leadership recognition, while technical analysis indicates the stock is trading near key support at $66.
The investment outlook presents a dichotomy between strong analyst conviction (90.9% buy ratings, $81 consensus target) and challenging fundamentals. While operational improvements and genomic testing growth offer potential upside, persistent losses and negative cash flow trends create significant execution risk. The stock's current position near support levels combined with oversold RSI readings suggests potential for near-term bounce, but sustainable gains require meaningful profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Gold Miners ETF
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
